{
    "clinical_study": {
        "@rank": "28299", 
        "brief_summary": {
            "textblock": "This is a single arm, single center pilot study of 40 patients with uT3N0 or uT1-3N+ rectal\n      cancer receiving pre-operative chemoradiation.  Subjects will undergo PET/MRI scans before\n      and after surgery.\n\n      The primary purpose of this study is to determine the negative predictive value of PET/MRI\n      for determining pathological complete response from neoadjuvant chemoradiation."
        }, 
        "brief_title": "PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study", 
        "completion_date": {
            "#text": "October 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Rectal Carcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Rectal Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Low-lying, low- to moderate-risk pathologically-confirmed rectal cancer (stage uT3n)\n             or uT1-3N+\n\n          -  Negative workup for distant disease\n\n          -  > 18 years of age\n\n          -  Pre-treatment workup completed including:\n\n          -  history and physical\n\n          -  CT or MRI of the abdomen and pelvis\n\n          -  endoscopic tumor evaluation (biopsy, blood work to assess CEA and hematopoietic,\n             renal and liver function)\n\n          -  if female of child-bearing age, negative pregnancy test\n\n          -  Recommendation to undergo preoperative concurrent chemoradiation, as determined by\n             the treating physician\n\n          -  Informed consent reviewed and signed\n\n        Exclusion Criteria:\n\n          -  Not deemed a candidate for preoperative chemoradiation for medical reasons, such as\n             uncontrolled infection (including HIV), uncontrolled diabetes mellitus or cardiac\n             disease\n\n          -  Hemoglobin \u2264 10.0 g/dL (transfusion allowed to achieve or maintain levels)\n\n          -  ANC \u2264 1,500/cubic mm\u00b3\n\n          -  Platelet count \u2264 100,000/mm\u00b3\n\n          -  ALT and AST \u2265 2.5 times upper level of normal (ULN)\n\n          -  Alkaline phosphatase \u2265 2.5 times ULN\n\n          -  Total bilirubin \u2265 1.5 times ULN\n\n          -  Creatinine clearance < 50 mL/min\n\n          -  Creatinine \u2265 1.5 times ULN\n\n          -  Not deemed a candidate for concurrent preoperative chemoradiation for social reasons,\n             such as psychiatric illness\n\n          -  Not deemed a surgical candidate\n\n          -  Currently active second malignancy, except non-melanoma skin cancer, non-invasive\n             bladder cancer, low risk adenocarcinoma of the prostate and carcinoma in situ of the\n             cervix\n\n          -  Previous pelvic radiation therapy\n\n          -  History of severe reaction to gadolinium\n\n          -  Inability to tolerate MRI (e.g., inability to lie flat for > 1 hour)\n\n          -  Presence of a pacemaker, intracranial aneurysm clip, bladder stimulator, cochlear\n             implant or metal near eyes\n\n          -  Body Mass Index (BMI) > 35\n\n          -  Pregnant or lactating female"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "UNC Hospitals"
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01751516", 
            "org_study_id": "LCCC1225"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 19, 2013", 
        "location": {
            "contact": {
                "email": "riguera@email.unc.edu", 
                "last_name": "Dorothy Riguera, BS", 
                "phone": "919-843-5420"
            }, 
            "facility": {
                "address": {
                    "city": "Chapel Hill", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27599"
                }, 
                "name": "University of North Carolina-Chapel Hill"
            }, 
            "investigator": [
                {
                    "last_name": "Joel Tepper, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Z. Andrew Wang, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Seth Miller, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Benjamin Calvo, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Amir Khandani, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Bert O'Neil, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Kevin Greene, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "W. Brian Hyslop, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "David Lalush, PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "PET/MRI as a Predictor for Response to Preoperative Radiation Therapy and Chemotherapy in Resectable Rectal Cancer: a Pilot Study.", 
        "overall_contact": {
            "email": "riguera@email.unc.edu", 
            "last_name": "Dorothy A Riguera, BS", 
            "phone": "919-843-5420"
        }, 
        "overall_official": {
            "affiliation": "University of North Carolina, Chapel Hill", 
            "last_name": "Joel E Tepper, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Data and Safety Monitoring Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Negative post-chemoradiation PET/MRI scan, as correlated with surgical pathology", 
            "safety_issue": "No", 
            "time_frame": "4-8 weeks post-chemoradiation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01751516"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Recurrence-free survival", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "Disease-specific survival", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "Overall survival", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }
        ], 
        "source": "UNC Lineberger Comprehensive Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "UNC Lineberger Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}